title: [Setting up indicators in biobanking: why and how?].
abstract: The biobanking area is highly complex, and its complexity is increasing along with its growth and demand. Due to the advancements in genetic research, stem cell research and regenerative medicine, biobanking has become ever more important and plays a key role in biomedical research. The robustness and the reproducibility of research results depend greatly on the quality and on the number of the samples used, and thus on the expertise of biobanks having supplied these samples. Undoubtedly, the recognition of a research biobank depends on the impact of the research projects conducted with samples obtained from tumour bank(s), but also on many other criteria. It thus seems important to determine a number of indicators within a biobank to estimate objective criteria for the performance of these structures. These indicators can allow to make some strategic decisions knowing that biobanks are expensive structures to maintain in the present hospital context. The use of these indicators could also contribute to the elaboration of an "biobank impact factor of" or so called "bioresource research impact factor" (BRIF). We describe here four major categories of indicators (quality, activity, scientific production, visibility), which seem to be useful for the evaluation of a biobank by making a proposition of allocation of coefficients for the various considered items.
authors.affiliation: Tumorothèque-centre de ressources biologiques, université de Nice Sophia-Antipolis, hôpital Pasteur, CHU, Nice, France.
authors.forename: Véronique
authors.initials: V
authors.lastname: Hofman
authors.forename: Marie-Clotilde
authors.initials: MC
authors.lastname: Gaziello
authors.forename: Christelle
authors.initials: C
authors.lastname: Bonnetaud
authors.forename: Marius
authors.initials: M
authors.lastname: Ilie
authors.forename: Virginie
authors.initials: V
authors.lastname: Mauro
authors.forename: Elodie
authors.initials: E
authors.lastname: Long
authors.forename: Eric
authors.initials: E
authors.lastname: Selva
authors.forename: Virginie
authors.initials: V
authors.lastname: Gavric-Tanga
authors.forename: Sandra
authors.initials: S
authors.lastname: Lassalle
authors.forename: Catherine
authors.initials: C
authors.lastname: Butori
authors.forename: Caroline
authors.initials: C
authors.lastname: Papin-Michaud
authors.forename: Nathalie
authors.initials: N
authors.lastname: Lerda
authors.forename: Olivier
authors.initials: O
authors.lastname: Bordone
authors.forename: Céline
authors.initials: C
authors.lastname: Coelle
authors.forename: Jean-Christophe
authors.initials: JC
authors.lastname: Sabourin
authors.forename: Christian
authors.initials: C
authors.lastname: Chabannon
authors.forename: Paul
authors.initials: P
authors.lastname: Hofman
mesh_terms: D035843:Biomedical Research; D006801:Humans; D009369:Neoplasms; D011643:Publishing; D011786:Quality Control; D014015:Tissue Banks / Q000458:organization & administration* / Q000592:standards*